Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × Sorafenib × Clear all

NCT00634751 2019-11-26

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

Phase 1/2 Completed

48 enrolled 13 charts

Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms